| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 228.56B | 230.78B | 244.32B | 260.41B | 201.55B | 164.82B |
| Gross Profit | 36.79B | 38.03B | 35.32B | 27.77B | 26.17B | 33.87B |
| EBITDA | 11.32B | 12.64B | 11.93B | 5.53B | 4.78B | 11.52B |
| Net Income | 6.29B | 7.00B | 6.79B | 986.00M | 1.95B | 5.25B |
Balance Sheet | ||||||
| Total Assets | 169.85B | 170.16B | 178.09B | 178.62B | 161.70B | 156.51B |
| Cash, Cash Equivalents and Short-Term Investments | 12.06B | 11.95B | 4.25B | 2.42B | 3.58B | 7.85B |
| Total Debt | 25.09B | 25.32B | 29.98B | 45.93B | 32.10B | 19.75B |
| Total Liabilities | 63.87B | 63.87B | 76.04B | 84.35B | 67.17B | 62.03B |
| Stockholders Equity | 105.50B | 105.81B | 101.61B | 93.85B | 94.13B | 94.11B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 13.82B | 18.82B | -13.99B | -20.75B | 870.00M |
| Operating Cash Flow | 0.00 | 18.29B | 22.47B | -10.02B | -16.81B | 4.27B |
| Investing Cash Flow | 0.00 | -3.78B | -3.34B | -3.71B | 1.92B | -2.44B |
| Financing Cash Flow | 0.00 | -6.86B | -17.35B | 12.63B | 10.58B | -2.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥45.25B | 10.79 | ― | 2.55% | 8.21% | 20.27% | |
71 Outperform | ¥586.74B | 19.60 | 9.28% | 1.30% | 5.50% | 27.32% | |
69 Neutral | ¥194.39B | 9.91 | 12.56% | 3.44% | 3.80% | 63.03% | |
69 Neutral | ¥23.29B | 2.45 | ― | 2.54% | 2.80% | 154.89% | |
67 Neutral | ¥69.38B | 20.57 | ― | 3.77% | -3.91% | -25.32% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | ¥316.34B | 10.01 | ― | 1.45% | 20.02% | ― |